Table 2.
Multiple regression models for identifying the association between central obesity and baPWV in subjects with MetS
| baPWV | |||||
|---|---|---|---|---|---|
| R 2 | B | SE | β | P | |
| MetS with CeO | |||||
| Model 1 | 0.010 | -76.001 | 24.842 | -0.099 | <0.001 |
| Model 2 | 0.191 | -88.328 | 22.480 | -0.115 | <0.001 |
| Model 3 | 0.191 | -85.560 | 23.077 | -0.111 | <0.001 |
| Model 4 | 0.191 | -85.537 | 23.090 | -0.111 | <0.001 |
| Model 5 | 0.257 | -70.866 | 22.208 | -0.092 | 0.001 |
| Model 6 | 0.258 | -70.392 | 22.207 | -0.091 | 0.002 |
| Model 7 | 0.260 | -78.961 | 22.741 | -0.103 | 0.001 |
| Model 8 | 0.285 | -84.231 | 25.272 | -0.109 | 0.001 |
β, standardized coefficients; B, unstandardized coefficients; baPWV, brachial-ankle pulse wave velocity; CeO, central obesity; LDL, low-density lipoprotein; MetS, metabolic syndrome; SE, standard error.
“Other MetS components” refer to the dichotomous variables of HDL cholesterol, triglycerides, blood pressure, and fasting glucose according to the NCEP–ATP III criteria.
Model 1: Unadjusted.
Model 2: Adjusted for age.
Model 3: Adjusted for age and male gender.
Model 4: Adjusted for age, male gender, and smoking.
Model 5: Adjusted for age, male gender, smoking, and heart rate.
Model 6: Adjusted for age, male gender, smoking, heart rate, and serum creatinine.
Model 7: Adjusted for age, male gender, smoking, heart rate, serum creatinine, and number of MetS components.
Model 8: Adjusted for age, male gender, smoking, heart rate, serum creatinine, number of MetS components, and other MetS components.